感染性主动脉瘤诊疗进展

doi:10.6040/j.issn.1671-7554.0.2024.0323

摘要/Abstract

摘要： 感染性主动脉瘤(infective native aortic aneurysm, INAA)是一种罕见且致命的感染性疾病,由病原微生物(主要为细菌)破坏主动脉管壁而引起。感染性主动脉瘤进展较快、病情复杂、破裂率高、预后较差,其诊断与治疗一直是血管外科领域的热点与难点。本文根据感染性主动脉瘤领域发表的相关文献,综述其病因学、病理生理学、临床表现、诊断、治疗和并发症,以期为今后感染性主动脉瘤的相关研究和诊疗提供指导。

关键词: 感染性主动脉瘤, 腹主动脉瘤, 腔内修复, 开放手术, 血管外科, 综述

Abstract: Infective native aortic aneurysm(INAA)is a rare and highly lethal disease in the field of vascular surgery, caused by degeneration and destruction of the aortic wall with the microorganism(mostly by bacteria). INAA has rapid progress, complicated symptoms, high rupture risk and poor prognosis. The diagnosis and treatment of INAA remain foci and challenges in vascular surgery. This review discussed the etiology, pathogenesis, clinical symptoms, diagnosis, treatment and complications of INAA based on the published papers and our management experiences, in order to provide advice to the future research and managements.

Key words: Infective native aortic aneurysm, Abdominal aortic aneurysm, Endovascular repair, Open repair, Vascular surgery, Literature review

中图分类号:

R543.1

霍正坤,孔祥骞,吴学君. 感染性主动脉瘤诊疗进展[J]. 山东大学学报 (医学版), 2024, 62(9): 42-48.

HUO Zhengkun, KONG Xiangqian, WU Xuejun. Progress in diagnosis and treatment of infective native aortic aneurysm[J]. Journal of Shandong University (Health Sciences), 2024, 62(9): 42-48.

参考文献

[1] Osler W. The gulstonian lectures, on malignant endocarditis[J]. Br Med J, 1885, 1(1262): 577-579.
[2] Sörelius K, Wyss TR, Academic Research Consortium of Infective Native Aortic Aneurysm, et al. Editors choice- infective native aortic aneurysms: a Delphi consensus document on terminology, definition, classification, diagnosis, and reporting standards[J]. Eur J Vasc Endovasc Surg, 2023, 65(3): 323-329.
[3] Ballaith A, Raffort J, Rajhi K, et al. Mycotic aortic and left iliac ruptured aneurysm due to Escherichia Coli: a case report and literature overview[J]. Acta Chir Belg, 2022,122(1): 56-62.
[4] Wilson WR, Bower TC, Creager MA, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association[J]. Circulation, 2016, 134(20): e412-e460.
[5] Dang Q, van Eps RGS, Wever JJ, et al. Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair in The Netherlands[J]. J Vasc Surg, 2020, 72(2): 531-540.
[6] Lin CH, Hsu RB. Primary infected aortic aneurysm: clinical presentation, pathogen, and outcome[J]. Acta Cardiol Sin, 2014, 30(6): 514-521.
[7] Luo CY, Ko WC, Kan CD, et al. In situ reconstruction of septic aortic pseudoaneurysm due to Salmonella or Streptococcus microbial aortitis: long-term follow-up[J]. J Vasc Surg, 2003, 38(5): 975-982.
[8] Lee CH, Hsieh HC, Ko PJ, et al. Treatment of infected abdominal aortic aneurysm caused by Salmonella[J]. Ann Vasc Surg, 2014, 28(1): 217-226.
[9] Huang YK, Chen CL, Lu MS, et al. Clinical, microbiologic, and outcome analysis of mycotic aortic aneurysm: the role of endovascular repair[J]. Surg Infect, 2014, 15(3): 290-298.
[10] Sörelius K, Wanhainen A, Furebring M, et al. Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair[J]. Circulation, 2016, 134(23): 1822-1832.
[11] Barry IP. Mycotic abdominal aortic aneurysm in the endovascular era[J]. Cureus, 2019, 11(11): e6119. doi:10.7759/cureus.6119.
[12] Murakami M, Morikage N, Samura M, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis of infected aortic aneurysms[J]. Ann Vasc Surg, 2014,28(3):575-578.
[13] Xue J, Yao YM, Liu LM. Treatment of tuberculous aortic pseudoaneurysm associated with vertebral tuberculosis: a case series and a literature review[J]. Medicine, 2018, 97(15): e0382. doi:10.1097/MD.0000000000010382.
[14] Lopes RJ, Almeida J, Dias PJ, et al. Infectious thoracic aortitis: a literature review[J]. Clin Cardiol, 2009, 32(9): 488-490.
[15] Berchiolli R, Mocellin DM, Marconi M, et al. Ruptured mycotic aneurysm after intravesical instillation for bladder tumor[J]. Ann Vasc Surg, 2019, 59: 310. doi:10.1016/j.avsg.2018.12.100.
[16] Flynn D, Ogi A, Subedi S, et al. Mycotic aortic aneurysm formation following intravesical BCG treatment for transitional cell carcinoma of the bladder[J]. BMJ Case Rep, 2021, 14(11): e246389. doi:10.1136/bcr-2021-246389.
[17] Kordzadeh A, Rhodes KM, Hanif MA, et al. Ruptured cryptogenic mycotic abdominal aortic aneurysm by Salmonella enteritidis[J]. Ann Vasc Surg, 2013, 27(7): 973. doi:10.1016/j.avsg.2012.08.016.
[18] Al-Ani HH, Khashram M, Dean A, et al. Infected abdominal aortic aneurysm after transrectal ultrasound-guided biopsy of the prostate: a report of two cases[J]. Ann Vasc Surg, 2019, 61: 469. doi:10.1016/j.avsg.2019.05.021.
[19] Banks CA, Beck AW, McFarland GE, et al. Concomitant paravisceral and thoracic mycotic aortic aneurysms in a cirrhotic patient[J]. J Vasc Surg Cases Innov Tech, 2021, 7(3): 496-501.
[20] Jabońska A, Zagrapan B, Paradowska E, et al. Abdominal aortic aneurysm and virus infection: a potential causative role for cytomegalovirus infection?[J]. J Med Virol, 2021, 93(8): 5017-5024.
[21] Sörelius K, Wanhainen A, Furebring M, et al. The microbiology of infective native aortic aneurysms in a population-based setting[J]. Ann Vasc Surg, 2022, 78: 112-122. doi:10.1016/j.avsg.2021.06.039.
[22] 黄伯儒, 高占峰. 布鲁菌感染性腹主动脉瘤腔内治疗前后细胞因子的表达情况[J]. 血管与腔内血管外科杂志, 2023,9(10): 1162-1166. Huang Boru, Gao Zhanfeng. Expression of cytokines in abdominal aortic aneurysms infected by Brucella before and after intracavitary therapy[J] Journal of Vascular and Endovascular Surgery, 2023, 9(10): 1162-1166.
[23] Kang J, Kim YW, Kim DK, et al. Culture-negative mycotic aortic aneurysms probably have a less severe clinical nature than culture-positive counterparts[J]. Ann Vasc Surg, 2021, 75: 150-161. doi:10.1016/j.avsg.2021.03.018.
[24] Maleszewski JJ. Inflammatory ascending aortic disease: perspectives from pathology[J]. J Thorac Cardiovasc Surg, 2015, 149(Suppl 2): S176-S183.
[25] Roncati L, Bernardelli G, Manenti A. The infected abdominal aortic aneurysm[J]. Ann Vasc Surg, 2020, 65: e297-e298. doi:10.1016/j.avsg.2020.01.082.
[26] Bayliss CD, Booth KL, Williams R, et al. Managing a mycotic thoracoabdominal aneurysm: the importance of molecular diagnostics[J]. Ann Thorac Surg, 2017, 104(5): e379-e381.
[27] Lakhani DA, Sharma SA, Kutayni H, et al. Primary aortoenteric fistula: a case report and brief review of the literature[J]. Radiol Case Rep, 2021, 16(11): 3549-3553.
[28] Cullen JM, Booth AT, Mehaffey JH, et al. Clinical characteristics and longitudinal outcomes of primary mycotic aortic aneurysms[J]. Angiology, 2019, 70(10): 947-951.
[29] Wanhainen A, Verzini F, van Herzeele I, et al. Editor’s choice - European society for vascular surgery(ESVS)2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms[J]. Eur J Vasc Endovasc Surg, 2019, 57(1): 8-93.
[30] Sörelius K, Mani K, Björck M, et al. Endovascular treatment of mycotic aortic aneurysms: a European multicenter study[J]. Circulation, 2014, 130(24): 2136-2142.
[31] Silvestri V, DEttorre G, Borrazzo C, et al. Many different patterns under a common flag: aortic pathology in HIV-a review of case reports in literature[J]. Ann Vasc Surg, 2019, 59: 268-284. doi:10.1016/j.avsg.2019.01.016.
[32] Luo YD, Zhu JC, Dai XC, et al. Endovascular treatment of primary mycotic aortic aneurysms: a 7-year single-center experience[J]. J Int Med Res, 2018, 46(9): 3903-3909.
[33] Reise-Filteau M, Toliopoulos P, Desilets E. A178 diagnosis of a mycotic aortic aneurysm using endoscopic ultrasound: a case report[J]. J Can Assoc Gastroenterol, 2020, 3(Suppl 1): 44-45.
[34] Lai CH, Chang RS, Luo CY, et al. Mycotic aneurysms in the abdominal aorta and iliac arteries: CT-based grading and correlation with surgical outcomes[J]. World J Surg, 2013, 37(3): 671-679.
[35] 赵娜, 侯小明, 张兴华, 等. 感染性主动脉瘤的CT血管成像特征[J]. 中国医学影像学杂志, 2023, 31(11): 1218-1221. ZHAO Na, HOU Xiaoming, ZHANG Xinghua, et al. CT angiography features of infective aortic aneurysm[J]. Chinese Journal of Medical Imaging, 2023, 31(11): 1218-1221.
[36] Zhang N, Xiong W, Li Y, et al. Imaging features of mycotic aortic aneurysms[J]. Quant Imaging Med Surg, 2021, 11(6): 2861-2878.
[37] Soussan M, Nicolas P, Schramm C, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis[J]. Medicine, 2015, 94(14): e622. doi:10.1097/MD.0000000000000622
[38] Sailer AM, Bakers FC, Daemen JW, et al. 18F-FDG PET/MRI in the diagnosis of an infected aortic aneurysm[J]. Cardiovasc Diagn Ther, 2018, 8(Suppl 1): S208-S211.
[39] Roldan CJ. Penetrating atherosclerotic ulcerative disease of the aorta: do emergency physicians need to worry?[J]. J Emerg Med, 2012, 43(1): 196-203.
[40] Sörelius K, Budtz-Lilly J, Mani K, et al. Systematic review of the management of mycotic aortic aneurysms[J]. Eur J Vasc Endovasc Surg, 2019, 58(3): 426-435.
[41] Aoki C, Fukuda W, Kondo N, et al. Surgical management of mycotic aortic aneurysms[J]. Ann Vasc Dis, 2017, 10(1): 29-35.
[42] Qi YF, Xiao ZX, Shu C, et al. Infected abdominal aortic aneurysms treated with extra-anatomic prosthesis bypass in the retroperitoneum[J]. Ann Vasc Surg, 2017, 45: 231-238. doi:10.1016/j.avsg.2017.06.125.
[43] 薛云飞, 罗明尧, 舒畅, 等. 主动脉假性动脉瘤急诊腔内修复术中“病灶内导管预置法”的运用[J]. 中国循环杂志, 2021, 36(1): 57-62. XUE Yunfei, LUO Mingyao, SHU Chang, et al. Emergency endovascular repair of aortic pseudoaneurysm combined with a pre-placed catheter into the lesions[J]. Chinese Circulation Journal, 2021, 36(1): 57-62.
[44] Stenson KM, Grima MJ, Loftus IM, et al. Recommendations for management of infected aortic pathology based on current evidence[J]. Semin Vasc Surg, 2019, 32(1/2): 68-72.
[45] Samson RH, Showalter DP, Lepore MR Jr, et al. Improved patency after axillofemoral bypass for aortoiliac occlusive disease[J]. J Vasc Surg, 2018, 68(5): 1430-1437.
[46] Lee CH, Hsieh HC, Ko PJ, et al. In situ versus extra-anatomic reconstruction for primary infected infrarenal abdominal aortic aneurysms[J]. J Vasc Surg, 2011, 54(1): 64-70.
[47] Dubois M, Daenens K, Houthoofd S, et al. Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases[J]. Eur J Vasc Endovasc Surg, 2010, 40(4): 450-456.
[48] Kyriakides C, Kan Y, Kerle M, et al. 11-year experience with anatomical and extra-anatomical repair of mycotic aortic aneurysms[J]. Eur J Vasc Endovasc Surg, 2004, 27(6): 585-589.
[49] Puppinck P, Chevalier J, Ducasse E, et al. Primary infected aneurysm of the infra-renal aorta: in situ or extra-anatomic bypass?[J]. J Mal Vasc, 2004, 29(1): 35-38.
[50] Ben Ahmed S, Louvancourt A, Daniel G, et al. Cryopreserved arterial allografts for in situ reconstruction of abdominal aortic native or secondary graft infection[J]. J Vasc Surg, 2018, 67(2): 468-477.
[51] Han Y, Kwon TW, Park SJ, et al. The results of in situ prosthetic graft replacement for infected aortic disease[J]. World J Surg, 2018, 42(9): 3035-3041.
[52] Heinola I, Sörelius K, Wyss TR, et al. Open repair of mycotic abdominal aortic aneurysms with biological grafts: an international multicenter study[J]. J Am Heart Assoc, 2018, 7(12): e008104. doi:10.1161/JAHA.117.008104.
[53] Heinola I, Kantonen I, Jaroma M, et al. Editors choice- treatment of aortic prosthesis infections by graft removal and in situ replacement with autologous femoral veins and fascial strengthening[J]. Eur J Vasc Endovasc Surg, 2016, 51(2): 232-239.
[54] Tournaye E, Hollering P, De Roover D, et al. Staphylococcus aureus sepsis and hemoptysis as messengers of a rather impractically located mycotic aneurysm[J]. Acta Chir Belg, 2023, 123(4): 430-435.
[55] McHenry MC, Rehm SJ, Krajewski LP, et al. Vertebral osteomyelitis and aortic lesions: case report and review[J]. Rev Infect Dis, 1991, 13(6): 1184-1194.
[56] Hu SY, Hsieh MS, Chang YT, et al. Clinical features, management, and outcome of iliopsoas abscess associated with cardiovascular disorders: a hospital-based observational case series study[J]. BMC Musculoskelet Disord, 2019, 20(1): 474. doi:10.1186/s12891-019-2798-3.
[57] Xiao HJ, Hu B, Luo RM, et al. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis[J]. Virol J, 2020, 17(1): 166. doi:10.1186/s12985-020-01409-8.
[58] Kannoth S, Thomas SV. Intracranial microbial aneurysm(infectious aneurysm): current options for diagnosis and management[J]. Neurocrit Care, 2009, 11(1): 120-129.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed